Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07687667Not yet recruiting
Randomised trial of beinaglutide in polycystic ovary syndrome (PCOS) and infertility (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: Ongoing Pregnancy Rate. Planned start Jul 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07687667.